ID   SNU-333
AC   CVCL_5053
SY   SNU333
DR   KCLB; 00333
DR   Wikidata; Q54955174
RX   PubMed=10619961;
RX   PubMed=19956504;
RX   PubMed=27993170;
RX   PubMed=34490820;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 76 hours (PubMed=10619961).
CC   Microsatellite instability: Stable (MSS) (PubMed=10619961).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): KCLB=00333
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D3S1358: 17
ST   D5S818: 11,13
ST   D7S820: 9,13
ST   FGA: 22,23
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 18
//
RX   PubMed=10619961; DOI=10.1046/j.1464-410x.2000.00247.x;
RA   Shin K.-H., Ku J.-L., Kim W.-H., Lee S.-E., Lee C., Kim S.-W.,
RA   Park J.-G.;
RT   "Establishment and characterization of seven human renal cell
RT   carcinoma cell lines.";
RL   BJU Int. 85:130-138(2000).
//
RX   PubMed=19956504; DOI=10.4143/crt.2005.37.1.1;
RA   Ku J.-L., Park J.-G.;
RT   "Biology of SNU cell lines.";
RL   Cancer Res. Treat. 37:1-19(2005).
//
RX   PubMed=27993170; DOI=10.1186/s12943-016-0565-8;
RA   Brodaczewska K.K., Szczylik C., Fiedorowicz M., Porta C.,
RA   Czarnecka A.M.;
RT   "Choosing the right cell line for renal cell cancer research.";
RL   Mol. Cancer 15:83.1-83.15(2016).
//
RX   PubMed=34490820; DOI=10.1177/15330338211038487;
RA   Chang I., Ohn T., Moon D., Maeng Y.H., Jang B.G., Yoon S.-P.;
RT   "SNU-333 cells as an appropriate cell line for the orthotopic renal
RT   cell carcinoma model.";
RL   Technol. Cancer Res. Treat. 20:15330338211038487.1-15330338211038487.11(2021).
//